# A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions

> **NCT03017014** · — · TERMINATED · sponsor: **AbbVie** · enrollment: 62 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03017014
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-26
- **Primary completion:** 2019-10-14
- **Final completion:** 2019-10-14
- **Target enrollment:** 62 (ACTUAL)
- **Why stopped:** Low enrollment
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03017014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03017014, "A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03017014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*